chartexchange

Hospital stocks in focus: Why Apollo and Fortis rose while HCG fell after 30% cancer drug margin cap

Trade Brains | Oct 9, 2026 7:25 AM EDT

The cap is meant to cut cancer drug prices by up to 70% and save patients about Rs 2,500 crore a year, and it applies to branded and generic, domestic and imported, and patented and non-patented medicines. The government says manufacturers' selling prices and revenues stay untouched, since the cap targets mark-ups in the distribution chain, and drugmakers must keep production at current levels. The timing matters, as the Supreme Court hears a case on drug mark-ups on October 12, after questioning how a drug bought for about Rs 2,700 could carry an MRP near Rs 27,000. Hospital shares reacted as investors tried to work out who gains and who loses.

Also Read: SEPC in focus after signing ₹854.57 Crore contract with SAIL-IISCO Steel Plant; Order book crosses ₹10,000 Cr

1. Apollo Hospitals
India's biggest private hospital chain was among the gainers, as investors judged that the cap would hurt hospital profits only marginally. Analysts said the move was not new to the market and was better than the 16% cap some had feared. ICICI Securities' Abdulkader Puranwala estimated the effect on hospital EBITDA at around 1-2%.
Shares of Apollo Hospitals Enterprise Ltd. were closed at Rs. 8,027.50, up 4.72 percent from previous close of Rs. 7,666.00. The stock opened at Rs. 7,950.00 reaching an intraday high of Rs. 8.027.50 and low of Rs. 7,775.50.
About the company: Apollo Hospitals is a Chennai-based healthcare group, founded in 1983 by Dr Prathap C Reddy. Besides hospitals, it runs pharmacies and digital health services.
2. Fortis Healthcare
Fortis was the strongest of the large names, rising nearly 4%. Other analyst estimates for the earnings impact range from 1% to 4%, depending on how much of a hospital's business comes from cancer care and how much it earns on medicines. For a multi-speciality network, oncology is only one part of the picture.
Shares of Fortis Healthcare Ltd. were closed at Rs. 786.25, up 3.05 percent from previous close of Rs. 763.00. The stock opened at Rs. 788.00 reaching an intraday high of Rs. 806.00 and low of Rs. 778.00.
About the company: Fortis Healthcare is a Gurugram-based hospital and diagnostics group with a network of multi-speciality hospitals across India.
3. Manipal Health Enterprises
Manipal advanced 3% as investors treated the news as manageable for large, diversified hospital chains. Puranwala also said he did not expect hospital margins to be affected by curbs on freebies to doctors, a separate worry in the sector.
Shares of Manipal Health Enterprises Ltd. were closed at Rs. 701.30, up 2.52 percent from previous close of Rs. 684.05. The stock opened at Rs. 683.45 reaching an intraday high of Rs. 716.00 and low of Rs. 683.45.
About the company: Manipal Health Enterprises is a Bengaluru-based hospital network from the Manipal Group, one of India's largest hospital chains.
4. Aster DM Healthcare
Aster DM climbed 2.5%, in line with the broader hospital rally. Like the other chains, it sells cancer drugs through its pharmacies, so a margin cap can nibble at income, but the company earns far more from its core hospital services.
Shares of Aster DM Healthcare Ltd. were closed at Rs. 699.85, up 3.35 percent from previous close of Rs. 677.15. The stock opened at Rs. 704.95 reaching an intraday high of Rs. 704.95 and low of Rs. 675.90.
About the company: Aster DM Healthcare is a hospital and clinic group with roots in Kerala and the Gulf, operating hospitals, clinics and pharmacies.
5. Healthcare Global Enterprises (HCG)
HCG was the odd one out, falling about 5.2% because its business is built around cancer care. Chairman BS Ajai Kumar told CNBC-TV18 that making and supplying some cancer drugs could become unviable when margins are already thin, and said drugmakers were reluctant to produce certain medicines for that reason. He added that the effect on quality of care needs to be studied, that low margins could hurt research, and that the details need a closer look since bulk purchase prices can differ.
Shares of Healthcare Global Enterprises Ltd. were closed at Rs. 589.20, down 7.76 percent from previous close of Rs. 638.75. The stock opened at Rs. 623.90 reaching an intraday high of Rs. 628.00 and low of Rs. 583.20. About the company: HCG is a Bengaluru-based chain of cancer hospitals, set up by Dr BS Ajai Kumar, who is its chairman.
What this means for investors
The 30% cap is a trade-off, with cheaper treatment for patients on one side and doubts about whether low-margin drugs will stay available on the other. The final list of covered medicines is still to be notified, and the Supreme Court hearing on October 12 could add more twists. Hospital stocks with little cancer exposure may feel little pain, while specialists carry more risk. Check earnings, valuations and exposure to oncology before acting on any of these moves.

Read original article